Mitaka, Japan

Motonobu Ichino


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1976-1977

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Motonobu Ichino: Innovator in Pharmaceutical Chemistry

Introduction

Motonobu Ichino is a notable inventor based in Mitaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of three patents to his name, Ichino's work has had a meaningful impact on medical science.

Latest Patents

Ichino's latest patents include innovative compounds such as (E)-2-[p-(.beta.-substituted-vinyl)phenyl]alkanoic acids. These compounds are represented by a specific formula and are known for their anti-inflammatory, analgesic, antipyretic, and platelet aggregation inhibitory activities. Another significant patent involves a process for preparing 2-thioadenosine, which serves as an intermediate for creating S-substituted-2-thioadenosines. These compounds exhibit platelet aggregation inhibitory activity and coronary vasodilating activity, showcasing Ichino's focus on cardiovascular health.

Career Highlights

Ichino is currently associated with Kohjin Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating new pharmaceutical products that address various health issues. His dedication to innovation in this field is evident through his patent filings and ongoing research.

Collaborations

Ichino has collaborated with esteemed colleagues such as Tokuro Nakamura and Hideo Suehiro. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in pharmaceutical chemistry.

Conclusion

Motonobu Ichino's contributions to the field of pharmaceutical chemistry are noteworthy, with his innovative patents paving the way for advancements in medical treatments. His work exemplifies the importance of research and collaboration in driving innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…